Skip to menu Skip to content Skip to footer
Professor Haitham Tuffaha
Professor

Haitham Tuffaha

Email: 
Phone: 
+61 7 334 61156

Overview

Background

I am the lead of the Effective and Efficient Healthcare program at the Centre for the Business and Economics of Health at The University of Queensland. I also lead Health Technology Assessment for the Centre, which involves evaluating submissions made to the Australian Government to reimburse new medicines and medical devices through the Pharmaceutical benefits Scheme (PBS) and the Medicare Benefits Schedule (MBS). My research is focused on the economic evaluation of health interventions to inform decision making and promote value-based health care. I have pioneered the application of Value of Information (Research) analysis to enhance the efficiency of clinical trials and maximise the return on investment from medical research.

I have extensive experience working with key stakeholders including consumers, clinicians, decision makers and researchers. I am chief investigator on over $45 million Category 1 grants from the NHMRC, MRFF and ARC. In addition, I lead several projects for the Department of Health and other peak organisations.

I chair the International Society for Pharmacoeconomics and Outcomes Research (ISPOR)-Oncology GroupI, and I am the past chair of the Clinical Oncology Society of Australia's (COSA)-Epidemiology Group and the Australian Clinical Trials Alliance (ACTA)-Research Prioritisation Group. I am an Associate Editor for Value in Health, and an Editorial Board Member for Medical Decision Making and PharmacoEconomics-open journals.

Availability

Professor Haitham Tuffaha is:
Available for supervision
Media expert

Qualifications

  • Doctor of Philosophy, Griffith University

Research interests

  • Economic Evaluation of Healthcare Interventions

  • Health Technology Assessment

  • Value-Based Health Care

  • Cancer Economics

  • Medications use and safety

Research impacts

My research has significantly influenced health policy in Australia and internationally and was pivotal in the allocation of almost $1 billion in new drugs and medical technologies in Australia over the past ten years. My research program about evaluating new health technologies using Value of Information/implementation analyses led to a paradigm shift in the economic evaluation of new interventions and improved patient access to health innovations (e.g., genetic testing, targeted therapies). My research shifted the way clinical trials are prioritised and funded towards a value-based approach, which informed the development of the Australian Clinical Trials Alliance Research Prioritisation Framework.

I have published over 100 peer reviewed articles and technical reports for leading organisations, including 45 technical reports for the Australian Government on the economic evaluation of novel drugs, devices and services for a range of conditions including cancer, genetic testing, cardiovascular disease and liver disease.

Works

Search Professor Haitham Tuffaha’s works on UQ eSpace

135 works between 2005 and 2025

121 - 135 of 135 works

2014

Journal Article

GCSF with or without chemotherapy compared to Plerixafor with GCSF as salvage mobilization regimen in patients with multiple myeloma and lymphoma: collection effectiveness and cost effectiveness analysis

Abdel-Rahman, Fawzi, Tuffaha, Haitham W, Sharma, Shanta, Jazar, Husam Abu, Hussein, Nilly, Saad, Adnan, Al Rawi, Omar and Hussein, Ayad (2014). GCSF with or without chemotherapy compared to Plerixafor with GCSF as salvage mobilization regimen in patients with multiple myeloma and lymphoma: collection effectiveness and cost effectiveness analysis. Journal of Oncology Pharmacy Practice, 20 (2), 130-136. doi: 10.1177/1078155213484785

GCSF with or without chemotherapy compared to Plerixafor with GCSF as salvage mobilization regimen in patients with multiple myeloma and lymphoma: collection effectiveness and cost effectiveness analysis

2014

Journal Article

Value of information analysis in healthcare: a review of principles and applications

Tuffaha, Haitham W., Gordon, Louisa G. and Scuffham, Paul A. (2014). Value of information analysis in healthcare: a review of principles and applications. Journal of Medical Economics, 17 (6), 377-383. doi: 10.3111/13696998.2014.907170

Value of information analysis in healthcare: a review of principles and applications

2014

Journal Article

Value of information analysis in oncology: the value of evidence and evidence of value

Tuffaha, Haitham W., Gordon, Louisa G. and Scuffham, Paul A. (2014). Value of information analysis in oncology: the value of evidence and evidence of value. Journal of Oncology Practice, 10 (2), e55-e62. doi: 10.1200/JOP.2013.001108

Value of information analysis in oncology: the value of evidence and evidence of value

2014

Journal Article

Cost-effectiveness analysis of clinically indicated versus routine replacement of peripheral intravenous catheters

Tuffaha, Haitham W., Rickard, Claire M., Webster, Joan, Marsh, Nicole, Gordon, Louisa, Wallis, Marianne and Scuffham, Paul A. (2014). Cost-effectiveness analysis of clinically indicated versus routine replacement of peripheral intravenous catheters. Applied Health Economics and Health Policy, 12 (1), 51-58. doi: 10.1007/s40258-013-0077-2

Cost-effectiveness analysis of clinically indicated versus routine replacement of peripheral intravenous catheters

2012

Journal Article

Revision and validation of a medication assessment tool for chronic cancer pain management

Salmany, Sewar S., Koopmans, Sara M., Treish, Imad M., El Jaber, Rana, Telfah, Shorouq and Tuffaha, Haitham W. (2012). Revision and validation of a medication assessment tool for chronic cancer pain management. The American Journal of Hospice and Palliative Medicine, 29 (8), 640-646. doi: 10.1177/1049909111435812

Revision and validation of a medication assessment tool for chronic cancer pain management

2012

Journal Article

Glucarpidase for the treatment of life-threatening methotrexate overdose

Tuffaha, H. W. and Al Omar, S. (2012). Glucarpidase for the treatment of life-threatening methotrexate overdose. Drugs of Today, 48 (11), 705-711. doi: 10.1358/dot.2012.48.11.1871575

Glucarpidase for the treatment of life-threatening methotrexate overdose

2012

Journal Article

Development and implementation of a method for characterizing clinical pharmacy interventions and medication use in a cancer center

Tuffaha, Haitham W and Koopmans, Sara M (2012). Development and implementation of a method for characterizing clinical pharmacy interventions and medication use in a cancer center. Journal of Oncology Pharmacy Practice, 18 (2), 180-185. doi: 10.1177/1078155211416529

Development and implementation of a method for characterizing clinical pharmacy interventions and medication use in a cancer center

2012

Conference Publication

THE EFFECTIVENESS AND COST EFFECTIVENESS OF PLERIXAFOR plus GCSF VERSUS GCSF +/- CHEMOTHERAPY AS SALVAGE MOBILIZATION REGIMENS IN LYMPHOMA AND MULTIPLE MYELOMA PATIENTS

Tuffaha, H. W., Hussein, A. A., Sharma, S., Abu-Jazar, H., Al-Rawi, O. S., Saad, A. M., Al-Zaben, A., Hussein, N. and Abdel-Rahman, F. A. (2012). THE EFFECTIVENESS AND COST EFFECTIVENESS OF PLERIXAFOR plus GCSF VERSUS GCSF +/- CHEMOTHERAPY AS SALVAGE MOBILIZATION REGIMENS IN LYMPHOMA AND MULTIPLE MYELOMA PATIENTS. BMT Tandem Meeting, San Diego Ca, Feb 01-05, 2012. NEW YORK: ELSEVIER SCIENCE INC. doi: 10.1016/j.bbmt.2011.12.130

THE EFFECTIVENESS AND COST EFFECTIVENESS OF PLERIXAFOR plus GCSF VERSUS GCSF +/- CHEMOTHERAPY AS SALVAGE MOBILIZATION REGIMENS IN LYMPHOMA AND MULTIPLE MYELOMA PATIENTS

2012

Conference Publication

COMPARATIVE COST UTILITY ANALYSIS OF PLERIXAFOR PLUS GCSF VERSUS CYCLOPHOSPHAMIDE PLUS GCSF AS SALVAGE MOBILIZATION REGIMENS IN MULTIPLE MYELOMA PATIENTS

Tuffaha, H. W., Hussein, A. A. and Abdel-Rahman, F. A. (2012). COMPARATIVE COST UTILITY ANALYSIS OF PLERIXAFOR PLUS GCSF VERSUS CYCLOPHOSPHAMIDE PLUS GCSF AS SALVAGE MOBILIZATION REGIMENS IN MULTIPLE MYELOMA PATIENTS. BMT Tandem Meeting, San Diego Ca, Feb 01-05, 2012. NEW YORK: ELSEVIER SCIENCE INC. doi: 10.1016/j.bbmt.2011.12.132

COMPARATIVE COST UTILITY ANALYSIS OF PLERIXAFOR PLUS GCSF VERSUS CYCLOPHOSPHAMIDE PLUS GCSF AS SALVAGE MOBILIZATION REGIMENS IN MULTIPLE MYELOMA PATIENTS

2012

Journal Article

Clinical pharmacy services in the outpatient pediatric oncology clinics at a comprehensive cancer center

Tuffaha, Haitham W., Abdelhadi, Ola and Al Omar, Suha (2012). Clinical pharmacy services in the outpatient pediatric oncology clinics at a comprehensive cancer center. International Journal of Clinical Pharmacy, 34 (1), 27-31. doi: 10.1007/s11096-011-9600-4

Clinical pharmacy services in the outpatient pediatric oncology clinics at a comprehensive cancer center

2012

Conference Publication

Adverse drug reactions in bone marrow transplant patients

Najjar, R., Tuffaha, H., Abdel-Rahman, F., Hussein, A. and Jazar, H. A. (2012). Adverse drug reactions in bone marrow transplant patients. 38th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT), Geneva, Switzerland, 1-4 April, 2012. London, United Kingdom: Nature Publishing Group. doi: 10.1038/bmt.2012.37

Adverse drug reactions in bone marrow transplant patients

2011

Journal Article

Glucarpidase rescue in a patient with high-dose methotrexate-induced nephrotoxicity

Tuffaha, Haitham W and Al Omar, Suha (2011). Glucarpidase rescue in a patient with high-dose methotrexate-induced nephrotoxicity. Journal of Oncology Pharmacy Practice, 17 (2), 136-40. doi: 10.1177/1078155209348720

Glucarpidase rescue in a patient with high-dose methotrexate-induced nephrotoxicity

2010

Journal Article

Successful stem-cell mobilization and transplantation using plerixafor in a patient with a germ cell tumor

Tuffaha, Haitham and Abdel-Rahman, Fawzi Abdel-Latif (2010). Successful stem-cell mobilization and transplantation using plerixafor in a patient with a germ cell tumor. Hematology/ Oncology and Stem Cell Therapy, 3 (4), 203-205. doi: 10.5144/1658-3876.2010.203

Successful stem-cell mobilization and transplantation using plerixafor in a patient with a germ cell tumor

2008

Journal Article

The use and effectiveness of granulocyte colony-stimulating factor in primary prophylaxis for febrile neutropenia in the outpatient setting

Tuffaha, Haitham W., Treish, Imad M. and Zaru, Luna (2008). The use and effectiveness of granulocyte colony-stimulating factor in primary prophylaxis for febrile neutropenia in the outpatient setting. Journal of Oncology Pharmacy Practice, 14 (3), 131-8. doi: 10.1177/1078155208091249

The use and effectiveness of granulocyte colony-stimulating factor in primary prophylaxis for febrile neutropenia in the outpatient setting

2005

Other Outputs

Implementation and validation of a method for characterising prescribing activity and associated pharmaceutical activity in haematology setting

Tuffaha, Haitham (2005). Implementation and validation of a method for characterising prescribing activity and associated pharmaceutical activity in haematology setting. M.Sc Thesis, School of Pharmacy, University of Strathclyde.

Implementation and validation of a method for characterising prescribing activity and associated pharmaceutical activity in haematology setting

Funding

Current funding

  • 2025 - 2030
    Centre of Research Excellence to Improve the QuALIty of SurVival in Gynaecological Cancer PatiEnts (ALIVE WELL)
    NHMRC Centres of Research Excellence
    Open grant
  • 2024 - 2028
    METASPATIAL Study: Metabolic Spatial Analysis of Lung Cancer Study
    NHMRC MRFF EMCR - Early to Mid-Career Researchers
    Open grant
  • 2024 - 2029
    Paediatric Immune Cell Atlas for Immunotherapy Innovation (PICACHIU)
    MRFF - National Critical Infrastructure Initiative
    Open grant
  • 2024 - 2029
    BrainCAR19 Study- Treatment of relapsed Primary Brain Lymphoma with CD19 directed CAR-T cells
    NHMRC MRFF CTA - Clinical Trials Activity
    Open grant
  • 2024 - 2028
    Effectiveness of a Healthy Lifestyle and Resilience Program in New-Onset Rheumatoid Arthritis
    NHMRC MRFF Clinician Researchers Applied Research in Health
    Open grant
  • 2024 - 2025
    Value-based assessment and cost-effectiveness analysis of two models of exercise oncology implementation
    Exercise and Sports Science Australia Ltd
    Open grant
  • 2023 - 2028
    ARC Research Hub for Advanced Manufacture of Targeted Radiopharmaceuticals
    ARC Industrial Transformation Research Hubs
    Open grant
  • 2023 - 2027
    Implementing integrated psychological and physical care for Australians after road traffic injury
    NHMRC MRFF Clinician Researchers: Nurses, Midwives and Allied Health Grant
    Open grant
  • 2023 - 2026
    Oral Health in Aged Care: Addressing Oral Health Inequity and Unmet Dental Care Needs of Vulnerable Population
    NHMRC MRFF Dementia, Ageing and Aged Care Mission
    Open grant
  • 2023 - 2026
    Personalising Innate-immunotherapy for Superior Treatment Outcomes with Large anticancer applicability (PISTOL)
    NHMRC MRFF EMCR - Early to Mid-Career Researchers
    Open grant
  • 2023 - 2025
    Research Alliance for Value-Based Care in Interventional Radiology
    Stryker Australia Pty Ltd
    Open grant
  • 2021 - 2025
    Prostate Cancer Survivorship Essentials for Men with Prostate Cancer on Androgen Deprivation Therapy: Transforming Care to Improve Outcomes (NHMRC Partnership Projects administered by USQ)
    University of Southern Queensland
    Open grant
  • 2020 - 2025
    EnhAnCing treatment oUtcoMes after gynaEcological caNcer (ACUMEN): Using exercise to promote health after cancer therapy
    NHMRC MRFF - Rare Cancers, Rare Diseases and Unmet Need
    Open grant

Past funding

  • 2023 - 2024
    Health economics analysis of animal plasma-derived antivenoms and antivenom distribution pathways for sub-Saharan Africa
    Global Snakebite Initiative USA Foundation
    Open grant
  • 2023
    A prospective clinical evaluation of prostate biopsy under local anaesthetic to optimise health care resources: feasibility study (RBWH Foundation Project Grant administered by Metro North Hospital)
    Metro North Hospital and Health Service
    Open grant
  • 2023
    Financial Efficiency Evaluation of PCFAs Prostate Cancer Specialist Nursing Program
    Prostate Cancer Foundation of Australia
    Open grant
  • 2022 - 2023
    Research Alliance for Value-Based Care in Interventional Radiology
    Stryker Australia Pty Ltd
    Open grant
  • 2022 - 2023
    The Value of Genetic Testing for Prostate Cancer
    Prostate Cancer Foundation of Australia
    Open grant
  • 2022 - 2023
    Efficacy and Effectiveness of Prophylactic fOam dressings in the prevention of saCral pressure injuries in at-risk hospitalised patients: The EEPOC Trial (NHMRC project grant administered by Griffith)
    Griffith University
    Open grant
  • 2022
    Cost-effectiveness analysis of lung cancer rehabilitation
    University of Melbourne
    Open grant
  • 2022
    Emerging and Adjunct treatments for PTSD and other mental health conditions affecting veterans: a rapid evidence assessment.
    Gallipoli Medical Research Foundation
    Open grant
  • 2021 - 2024
    BALANCE: Promoting wellBeing in AdoLescent and young Adult cancer survivors
    NHMRC Partnership Projects
    Open grant
  • 2021 - 2022
    Spillover Effects of Military Service on Health and Wellbeing in Veteran Families
    Gallipoli Medical Research Foundation
    Open grant
  • 2021
    A prospective clinical evaluation of prostate biopsy under local anaesthetic to optimise health care resources: feasibility study
    Metro North Hospital and Health Service
    Open grant
  • 2020
    Improving patient access to novel cancer drugs in Australia: striking the balance
    NHMRC Early Career Fellowships
    Open grant
  • 2017 - 2024
    ARC Training Centre for Innovation in Biomedical Imaging Technology
    ARC Industrial Transformation Training Centres
    Open grant

Supervision

Availability

Professor Haitham Tuffaha is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    Evaluation of Indonesian Chronic Diseases Management Program: Patients participation, adherence to the treatment and cost-effectiveness of the program

    Principal Advisor

    Other advisors: Associate Professor Adam La Caze, Dr Kim Edmunds

  • Doctor Philosophy

    Evaluation of Indonesian Chronic Diseases Management Program: Patients participation, adherence to the treatment and cost-effectiveness of the program

    Principal Advisor

    Other advisors: Associate Professor Adam La Caze, Dr Kim Edmunds

  • Doctor Philosophy

    Assessing the Value for Money of Integrating Exercise as Therapy after Gynaecological Cancer Treatment

    Principal Advisor

    Other advisors: Professor Sandie McCarthy

Completed supervision

Media

Enquiries

Contact Professor Haitham Tuffaha directly for media enquiries about:

  • Cancer Economics
  • Health Economics
  • Health Services Research

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au